Jeffrey Robert Ajer - 22 Mar 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
22 Mar 2022
Net transactions value
-$669,143
Form type
4
Filing time
24 Mar 2022, 20:49:18 UTC
Previous filing
17 Mar 2022
Next filing
31 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale $167,913 -2,073 -3.1% $81.00 65,385 22 Mar 2022 Direct F1
transaction BMRN Common Stock Sale $501,230 -6,129 -9.4% $81.78 59,256 23 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on February 28, 2022.